Drug
Emapunil clinical trials
Also written XBD173.
- studies test it
- 10
- open now
- 7
- in phase 3
- 0
- first study started
- 2005
Keep track of what changes. Save the emapunil studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2026 (3)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2014 | 2 |
| 2018 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 3
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 9
Imperial College London (8) · National Institute of Mental Health (NIMH) (1) · Novartis Pharmaceuticals (1)
Often tested with
Tested in the same studies.
Etifoxine (1)
Studies
Open first, then newest update. How each study uses emapunil is read from its arms, and is right about nine times in ten.
Testing it · 10
- TSPO Endothelial - EMPATHYEnrolling by invitationPhase 1Imperial College LondonNCT07697183Written as XBD173
- Role of a Mitochondrial Receptor in Blood Sugar RegulationRecruitingPhase 2Imperial College LondonNCT07682233Written as XBD173
- TSPO Occupancy in the Human LungEnrolling by invitationNot applicableImperial College LondonNCT07362290Written as XBD173
- Endothelial Cell Activation and Total Pulmonary Resistance in PAHNot yet recruitingNot applicableImperial College LondonNCT06035861Written as XBD173
- TSPO Modulation in ADEnrolling by invitationPhase 2Imperial College LondonNCT07191821Written as XBD173
- Validation of the 18 kiloDalton Translocator Protein (TSPO) as a Novel Neuroimmunodulatory TargetRecruitingNot applicableImperial College LondonNCT03850301Written as XBD173
- Targeting 18kDa Translocator Protein (TSPO) to Improve Brain Endothelial Cell Function in Cerebral Small Vessel DiseaseRecruitingNot applicableImperial College LondonNCT06643013Written as XBD173
- Reproducibility of the 11C-PBR28 PET SignalWithdrawnNot applicableImperial College LondonNCT02086240Written as XBD173
- Specific PET Radioligand Binding to Translocator ProteinCompletedPhase 1National Institute of Mental Health (NIMH)NCT02181582Written as Emapunil
- Efficacy, Safety and Tolerability of XBD173 in Patients With Generalized Anxiety DisorderCompletedPhase 2Novartis PharmaceuticalsNCT00108836Written as XBD173
Codes
What other systems call emapunil · ClinicalTrials.gg INT004799
- UNII (FDA) OG837L732JEMAPUNILConfirmed FDA, Wikidata
- Wikidata Q15408410emapunilConfirmed FDA, Wikidata
- NCI Thesaurus C82906EmapunilOne source FDA
- DrugBank DB12666One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | OG837L732J | EMAPUNIL | Confirmed FDA, Wikidata |
| Wikidata | Q15408410 | emapunil | Confirmed FDA, Wikidata |
| NCI Thesaurus | C82906 | Emapunil | One source FDA |
| DrugBank | DB12666 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.